Literature DB >> 24978426

Vertical canaliculotomy with retrograde expression of concretions for the treatment of canaliculitis.

Balaji Perumal1, Dale R Meyer.   

Abstract

PURPOSE: To evaluate the efficacy and safety of the technique of vertical canaliculotomy with retrograde expression of concretions for the treatment of canaliculitis.
METHODS: This is a retrospective, interventional case series. Patients who underwent vertical canaliculotomy by 1 surgeon (D.R.M.) from August 2011 to December 2013 were identified. On initial diagnosis of canaliculitis, all patients were treated with a combination antibiotic/steroid eyedrop and an oral antibiotic. The procedure was performed 1 month later and consisted of a 2-mm vertical canaliculotomy with sharp-tipped scissors followed by retrograde expression of the canalicular contents by compressing the canaliculus medial to lateral with 2 cotton-tipped applicators. All concretion specimens were sent for pathologic examination. Pre- and postoperative subjective complaints and objective findings on examination, including eyelid thickening and probing/irrigation results, were recorded.
RESULTS: Canalicular contents were readily expressed from all 8 patients who underwent the procedure. Pathologic analysis revealed Actinomyces species in 5 of 8 specimens and other Gram-negative and Gram-positive bacteria in the remaining specimens. All patients reported significant improvement in their symptoms and were patent to irrigation.
CONCLUSIONS: Many reported surgical procedures for the treatment of canaliculitis involve the use of a curette, an instrument with sharp edges, that could potentially damage the lining of the canaliculus. Previous studies examining these procedures have reported canalicular stricture and dysfunction postoperatively. The current technique of vertical canaliculotomy with retrograde expression of canalicular contents described herein has been effective, limits iatrogenic trauma, and had a low incidence of postoperative complications in this series.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24978426     DOI: 10.1097/IOP.0000000000000213

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  7 in total

1.  A Pathological Analysis of Canaliculitis Concretions: More Than Just Actinomyces.

Authors:  Balaji Perumal; John Andrew Carlson; Dale Robert Meyer
Journal:  Scientifica (Cairo)       Date:  2016-06-14

2.  Canaliculitis Awareness.

Authors:  Melike Balıkoğlu Yılmaz; Emine Şen; Ebru Evren; Ufuk Elgin; Pelin Yılmazbaş
Journal:  Turk J Ophthalmol       Date:  2016-01-05

3.  Clinical features and surgical outcomes of primary canaliculitis with concretions.

Authors:  Shengjin Xiang; Bin Lin; Qintuo Pan; Meiqin Zheng; Xiaoyi Qin; Youpei Wang; Zongduan Zhang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Surgical procedure of canaliculoplasty in the treatment of primary canaliculitis associated with canalicular dilatation.

Authors:  Yun Su; Leilei Zhang; Lunhao Li; Xianqun Fan; Caiwen Xiao
Journal:  BMC Ophthalmol       Date:  2020-06-20       Impact factor: 2.209

5.  Application of lacrimal endoscopy in the diagnosis and treatment of primary canaliculitis: Practical technique and graphic presentation.

Authors:  Qingqing Zheng; Ting Shen; Hongbo Luo; Chaoyang Hong; JinJing He; Jingwen Gong; Jin Jiang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

6.  Primary canaliculitis: The incidence, clinical features, outcome and long-term epiphora after snip-punctoplasty and curettage.

Authors:  Usha R Kim; Bhagwati Wadwekar; Lalitha Prajna
Journal:  Saudi J Ophthalmol       Date:  2015-09-07

7.  Actinomycetes canaliculitis complicating congenital nasolacrimal duct obstruction in an infant.

Authors:  Akshay Gopinathan Nair; Nayana A Potdar; Swaranjali S Gore; Amol Y Ganvir; Monisha K Apte; Trupti R Marathe; Chaya A Kumar; Chhaya A Shinde
Journal:  Indian J Ophthalmol       Date:  2018-04       Impact factor: 1.848

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.